- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Defiance Daily Target 2X Long HIMS ETF(HIMZ)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HIMZ
11/20/2026: HIMZ (1-star) is currently NOT-A-BUY. Pass it for now.
Defiance Daily Target 2X Long HIMS ETF (HIMZ) provides 2x daily leveraged exposure to the performance of Hims & Hers Health, Inc. (HIMS) using swap contracts and financial derivatives. Its primary strengths lie in offering efficient tactical upside amplification for short-term traders without needing a margin account. The fund serves as a short-term trading instrument rather than a long-term investment vehicle. Key risks include severe volatility decay over extended periods, high single-stock concentration, and a 1.33% expense ratio. It suits active momentum traders who closely monitor market positions and should be avoided by long-term passive investors.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | Leveraged single-stock ETFs are designed for short-term tactical trading rather than long-term capital growth. |
| Momentum investor | Strong fit while signal remains positive | Active momentum traders can use HIMZ to amplify short-term upside trends in HIMS stock when technical indicators are favorable. |
| Value investor | Weak fit | The fund's heavy reliance on derivatives and high daily turnover counters traditional value investment philosophies. |
| Dividend/Income investor | Weak fit | HIMZ does not focus on capital preservation or stable dividend generation. |
| Low-risk investor | Weak fit | Extreme volatility and daily compounding risks make this product completely unsuitable for low-risk profiles. |
Investor Profile
Ideal Investor Profile
The ideal investor is an active short-term trader or market professional with high risk tolerance who monitors positions intraday and seeks tactical 2x exposure to HIMS.
Suitability
Best suited exclusively for active short-term tactical trading rather than buy-and-hold investing.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Amplified daily tracking targets guarantee severe price swings and compounding volatility decay over time. |
| Market risk | High | The fund is completely exposed to adverse price movements in Hims & Hers Health. |
| Concentration | High | Performance is entirely dependent on a single underlying equity asset. |
| Tracking/expense | Medium / high | Compounding effects over multiple sessions mean multi-day returns will diverge from a clean 2x multiple of the underlying stock. |
| Liquidity | Medium | While daily volume is generally active, sudden shifts in underlying stock interest can widen spreads. |
| Business/sector quality | Medium / high | Investors face structural risks tied specifically to the telehealth and digital wellness execution of HIMS. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
HIMZ experiences extreme historical volatility driven by its 2x daily leveraged objective applied to a high-beta growth stock.
Market Risk
The fund carries intense single-issuer risk, meaning any negative operational, competitive, or regulatory event affecting Hims & Hers Health directly impacts the fund's value.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Single stock | Hims & Hers Health Inc. (HIMS) — seeks 2x daily return | 100 | Provides leveraged derivative exposure tied directly to the daily price fluctuations of Hims & Hers Health. |
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type ETF | Historic Profit -41.22% | Avg. Invested days 10 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

